Notable Options Activity in BAX

Shares of Baxter International

are lower on the session by 6.6%, currently trading at $54.20. The stock is down due to a delay announced by the FDA regarding its immune drug HyQ. Baxter is co-producing the drug with Halozyme. Options volatility is up significantly on the day with the April vol +7.0 and the May vol +4.4 points.. The strike seeing the heaviest action is the May 2012 $55.00 put, which has traded over 7,000 times on open interest of 11,000 contracts. Baxter International Inc. (Baxter,) is a global healthcare company. Baxter and its subsidiaries develop, manufacture and market products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.